Portfolio company
RS Research
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops targeted nanomedicine delivery platforms and polymer-drug conjugates for oncology patients and pharmaceutical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NaDeNo
This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.
Prosemble
This biotechnology company develops an artificial intelligence and nanotechnology platform to design protein-based nanoparticle systems for precise drug delivery to cancer patients.
Ariz Precision Medicine
The company develops targeted nanoparticle and siRNA therapies for cancer patients and pharmaceutical partners.
Exomnis Biotech
This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.
BioMoti
This company develops targeted drug delivery technology for cancer therapeutics, primarily serving the pharmaceutical and biotechnology industries.
Rezo Therapeutics
This biotechnology company develops drug discovery platforms and targeted therapies for oncology and other serious diseases, serving the pharmaceutical and healthcare industries.
PNAS Therapeutics
This company develops a one-step drug delivery platform to create regenerative therapies and enhanced pharmaceutical formulations for biotechnology and healthcare partners.
Engage Bio
This biotechnology company develops non-viral genetic medicines and mRNA immunotherapies for pharmaceutical partners to treat cancer and gene replacement disorders.
